semaglutide and levothyroxine Does (Ozempic) affect the efficacy of (T4)? How should a patient on
Description
In the OASIS 4 Phase 3 trial, adults taking oral semaglutide 25mg once daily alongside a reduced-calorie diet and lifestyle support lost an average of 16.6% of their body weight over 64 weeks, with full treatment adherence
Always follow the specific instructions provided with your prescription
Dont hesitate to sign up today to kickstart your clinician-guided GLP-1 plan and take a proactive step toward achieving your health goals
Horowitz, M., Rayner, C
